Hughes ADDIN EN.CITE European Genetic risk score of 5 -0.002 (-0.13, 0.13) 0.97 β 2013 7,979 (2)* DBP (mm Hg) 2.3% Caucasian SUA-related SNPs Yang ADDIN EN.CITE Genetic risk score of 8 -0.34 (-1.04, 0.35) 0.33 β 2010 American 20,699 (5)* DBP (mm Hg) 6.0% SUA-related SNPs Parsa ADDIN EN.CITE DBP-Clinic visit 1 0.52 (-0.62, 1.66) 0.36 2012 USA 868 rs16890979 in SCL2A9 NA MD (mm Hg) Parsa ADDIN EN.CITE DBP-High-salt 24-h 0.42 (-0.56, 1.40) 0.41 2012 USA 868 rs16890979 in SCL2A9 NA MD (mm Hg) Parsa ADDIN EN.CITE DBP-Low-salt 24-h 0.19 (-0.75, 1.13) 0.69 2012 USA 868 rs16890979 in SCL2A9 NA MD (mm Hg)
Hughes ADDIN EN.CITE 2013 European Caucasian 7,979 (2)* DBP (mm Hg) Genetic risk score of 5 SUA-related SNPs 2.3% β -0.002 (-0.13, 0.13) 0.97 Yang ADDIN EN.CITE 2010 American 20,699 (5)* DBP (mm Hg) Genetic risk score of 8 SUA-related SNPs 6.0% β -0.34 (-1.04, 0.35) 0.33 Parsa ADDIN EN.CITE 2012 USA 868 DBP-Clinic visit 1 (mm Hg) rs16890979 in SCL2A9 NA MD 0.52 (-0.62, 1.66) 0.36 Parsa ADDIN EN.CITE 2012 USA 868 DBP-High-salt 24-h (mm Hg) rs16890979 in SCL2A9 NA MD 0.42 (-0.56, 1.40) 0.41 Parsa ADDIN EN.CITE 2012 USA 868 DBP-Low-salt 24-h (mm Hg) rs16890979 in SCL2A9 NA MD 0.19 (-0.75, 1.13) 0.69
Supplementary%20material_v7%20-%20Final-2.docx